Oncosil Medical Ltd

Research Oncosil Medical Ltd (OSL) on Bullrun: market cap AUD 20.72M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerOSL
• ExchangeAU
• CountryAustralia
• SectorHealthcare
• IndustryMedical Devices
• CurrencyAUD
• Market capAUD 20.72M
• Financial periodFY2025
• RevenueAUD 1.17M
• Revenue growth126.6%
• Net income-AUD 15.10M
• Free cash flow-AUD 12.08M
• Gross margin-92.5%

Valuation Snapshot

latest market cap is AUD 20.72M.

About Oncosil Medical Ltd

OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company's lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.

Frequently asked questions

What is Oncosil Medical Ltd's market cap?

Oncosil Medical Ltd's market capitalization is AUD 20.72M.

What does Oncosil Medical Ltd do?

OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma.